Arcutis Biotherapeutics Inc (ARQT)
9.43
+0.17
(+1.84%)
USD |
NASDAQ |
Nov 18, 16:00
9.53
+0.10
(+1.06%)
Pre-Market: 08:33
Arcutis Biotherapeutics Shareholders Equity (Quarterly): 156.64M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 156.64M |
| June 30, 2024 | 186.43M |
| March 31, 2024 | 224.94M |
| December 31, 2023 | 88.67M |
| September 30, 2023 | 46.72M |
| June 30, 2023 | 80.51M |
| March 31, 2023 | 139.73M |
| December 31, 2022 | 209.58M |
| September 30, 2022 | 270.77M |
| June 30, 2022 | 195.38M |
| March 31, 2022 | 253.77M |
| Date | Value |
|---|---|
| December 31, 2021 | 297.68M |
| September 30, 2021 | 363.00M |
| June 30, 2021 | 414.49M |
| March 31, 2021 | 450.99M |
| December 31, 2020 | 270.62M |
| September 30, 2020 | 173.07M |
| June 30, 2020 | 208.92M |
| March 31, 2020 | 241.88M |
| December 31, 2019 | -65.03M |
| September 30, 2019 | -52.95M |
| December 31, 2018 | -23.99M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-65.03M
Minimum
Dec 2019
450.99M
Maximum
Mar 2021
210.44M
Average
209.25M
Median
Shareholders Equity (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | 232.02M |
| Biogen Inc | 16.36B |
| Vertex Pharmaceuticals Inc | 15.63B |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 437.35M |
| Total Liabilities (Quarterly) | 280.71M |
| Debt to Equity Ratio | 1.306 |
| Current Ratio | 2.457 |
| Net Debt Paydown Yield | -0.09% |